Cardiovascular
Industry Articles
-
Cardiovascular
Data Show Benefits of Vektor Medical's vMap Arrhythmia Mapping Tech
Study results demonstrate a 22.6% reduction in ablation procedure duration.Michael Barbella, Managing Editor 05.13.24
-
Cardiovascular
Paroxysmal Enrollment in Kardium's PULSAR IDE Study Completed
Trial aims to determine the safety/effectiveness of the firm's Globe System for atrial fibrillation treatment.Michael Barbella, Managing Editor 05.13.24
-
Cardiovascular
Biotronik Enrolls First Patient in BIOMAG-II Trial of Freesolve Resorbable Scaffold
The international trial will evaluate the Freesolve resorbable magnesium scaffold against a contemporary drug-eluting stent.Sam Brusco, Associate Editor 05.13.24
-
Cardiovascular
Medtronic's Pulsed Field Ablation Earns Japanese Approval
A new software upgrade also became available for the PulseSelect PFA system, which features an automated delivery mode.Sam Brusco, Associate Editor 05.10.24
-
Cardiovascular | Neurological
Route 92 Recalls Certain Neurovascular Catheters After 2 Injuries, 1 Death
The company said the affected Tenzing 7 catheters breaking at the proximal marker band were manufactured by an outside contract supplier.Sam Brusco, Associate Editor 05.10.24
-
Cardiovascular
Pulse Biosciences Completes First U.S. Procedure with Pulsed Field Ablation Electrode Tech
The system is comprised of a percutaneous needle electrode used with the proprietary CellFX nsPFA console.Sam Brusco, Associate Editor 05.10.24
-
Cardiovascular
Field Medical Starts First-in-Human Pulsed-Field Ablation Trial
Field Medical's founder and CEO was also the founder of PFA company Farapulse.Sam Brusco, Associate Editor 05.09.24
-
Cardiovascular
Edwards Rolls Out Sapien 3 Ultra Resilia TAVR in Europe
Resilia tissue has anti-calcification properties and can be stored under dry packaging conditions.Sam Brusco, Associate Editor 05.09.24
-
Cardiovascular
4C Medical Gets 2 FDA Breakthough Nods for AltaValve TMVR Device
The AltaValve transcatheter mitral valve replacement device differentiates from others with atrial-only fixation, preserving the native mitral valve.Sam Brusco, Associate Editor 05.08.24
-
Cardiovascular
Cleerly ISCHEMIA Demonstrates Diagnostic Accuracy in Clinical Trials
Coronary computed tomography angiography analyzed with Cleerly's AI-QCT ISCHEMIA device accurately assesses coronary ischemia, data show.Michael Barbella, Managing Editor 05.08.24
-
Cardiovascular
J&J's Biosense Webster Rolls Out AI-Enhanced Version of Heart-Mapping Tech
Carto 3 system Version 8 is the latest version of Biosense Webster's 3D heart mapping system for cardiac ablation procedures.Sam Brusco, Associate Editor 05.08.24
-
Cardiovascular | Neurological
CereVasc Nabs FDA IDE Nod for eShunt Trial to Treat Hydrocephalus
The STRIDE pivotal study will compare eShunt to a ventriculo-peritoneal shunt, the current standard of care for treating hydrocephalus.Sam Brusco, Associate Editor 05.07.24
-
Cardiovascular
Medtronic's Symplicity Spyral Renal Denervation System Approved in China
Symplicity Spyral is the first RDN technology to obtain approval from the NMPA.Sam Brusco, Associate Editor 05.06.24
-
Cardiovascular | Neurological
FDA OKs 2 New Scientia Vascular Microfabricated Catheters
Plato 17 is a DMSO-compatible microcatheter and Socrates 38 is an aspiration catheter for ischemic stroke.Sam Brusco, Associate Editor 05.06.24
-
Cardiovascular
ConKay Medical Systems Raises $1.8 Million in Seed Funding
The money will support the company's growth and development of its one-size-fits-all annular repair catheter system.Michael Barbella, Managing Editor 05.02.24
-
Cardiovascular
HeartBeam Begins Study of its AIMIGo System
Trial aims to demonstrate the equivalence of ECG waveforms between the AIMIGo synthesized 12-lead ECG and a standard 12-lead ECG.Michael Barbella, Managing Editor 05.02.24
-
Cardiovascular
Studies Support Favorable Outcomes With Edwards' SAPIEN TAVR
All Edwards TAVR platforms demonstrated excellent paravalvular leak results, according to the data.Michael Barbella, Managing Editor 05.01.24
-
Cardiovascular | Neurological
Route 92 Medical Gets FDA OK for FreeClimb 54 Reperfusion System
FreeClimb 54 can be used to remove distal clots, should first-line therapies fail to completely remove the clot.Sam Brusco, Associate Editor 04.30.24
-
Cardiovascular
WhiteSwell Shares Six-Month Results in its DELTA-HF Study
Data show fewer rehospitalizations for heart failure in the six months after eLym System treatment.Michael Barbella, Managing Editor 04.29.24
-
Cardiovascular
HeartSciences' MyoVista Wavelet Technology Now Protected in Canada
The company has been awarded eight utility patents and one design patent in the United States.Michael Barbella, Managing Editor 04.29.24
